The role of tTG IgA (tissue transglutaminase IgA) in menopause is not directly addressed in the provided knowledge base. tTG IgA is a well-established biomarker for celiac disease, an autoimmune condition triggered by gluten. There is some evidence that untreated celiac disease may influence the timing of menopause—potentially through chronic inflammation or malabsorption affecting hormonal balance. However, the given contexts lack specific studies or guidelines linking tTG IgA levels directly to menopausal symptoms such as hot flashes or bone density loss. Therefore, the evidence is rated as 'unclear.' Clinically, tTG IgA is used primarily for celiac diagnosis, not menopause assessment. In women with unexplained premature menopause or irregular cycles, celiac screening may be considered, but this is not a routine recommendation. This answer is based on general medical knowledge, not the specific RAG sources. Safety note: tTG IgA testing should only be performed when celiac disease is suspected; self-interpretation without medical guidance is not advisable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ccd25fd3abe832b57484ad1d